Posts Tagged ‘biogeneric’

Biosimilar drugs to gain greater priority as decade progresses

This is a guest post from Keith Bradbury, Executive Director of Drug Information at Medco Health Solutions, Inc. Biosimilar drugs to gain greater priority as decade progresses The Patient Protection and Affordable Care Act will heighten the degree of competition in the field of biotech drugs, a fast growing area of drug therapy that is […]


Biologic data exclusivity: The arguments for and against it

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology: Why data exclusivity is the new patent protection Peter J Pitts, Center for medicine in the public interest Follow-on biologic drug competition […]


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog